FDA recalls 3 epinephrine vial lots: who in Dubai should check stock by lot number

Dubai pharmacies and clinical operators should treat the FDA epinephrine alert as an inventory-control event, because the affected product is a prescription 30 mL multidose vial used under physician direction.

The highest-stakes readers are COOs, medical directors and pharmacy leads. The operational question is simple: does any Dubai facility hold US-sourced American Regent Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) with lot numbers 25128L1C0, 25280L1C0 or 26108L1C0? If yes, the product should be quarantined before a clinician reaches for it in an emergency trolley, procedure room or pharmacy store.

How the risk moves through Dubai supply

A defective prescription medicine moves through procurement, wholesaler delivery, pharmacy shelving, ward stock, crash carts and procedure-area emergency kits. In Dubai, that chain is overseen locally by the Dubai Health Authority (DHA), with medicine registration and safety alerts tied to federal systems under the Ministry of Health and Prevention (MOHAP) and the Emirates Drug Establishment. Abu Dhabi and Al Ain operators should check Department of Health Abu Dhabi (DOH) communications, while northern-emirate providers should check MOHAP channels.

The FDA notice, published on 3 September 2026, said American Regent recalled three lots after complaints about leaking and cracked vials. The company investigation also identified particulate matter including nylon, cellulosic, acrylic, polyethylene and glass. The affected US distribution windows ran from 4 September 2025 to 31 July 2026, depending on the lot.

"To date, American Regent has not received any reports of adverse events related to this recall." American Regent company announcement posted by the FDA, 3 September 2026.

Who is actually at risk

The exposed patient is usually someone treated in a facility that stocks injectable adrenaline for emergency use. The recalled presentation is a prescription multidose vial handled by trained staff. The higher-risk settings are emergency departments, ambulances, inpatient wards, intensive care units, endoscopy suites, dental surgery rooms and outpatient centres that stock adrenaline for anaphylaxis or resuscitation.

• Facility pharmacies: run a lot-number search across main stores, satellite pharmacies and automated dispensing cabinets.
• COOs: require written confirmation from suppliers if any epinephrine stock entered through parallel or special-order procurement.
• Medical directors: tell clinical teams that replacement stock must remain immediately available before recalled stock is removed from emergency areas.
• CFOs: check whether replacement, return or credit is handled by the distributor, because emergency-medicine stockouts create operational risk before they create a large drug-cost issue.

For patient-facing allergy care, the practical message is narrower. Epinephrine auto-injectors remain prescription medicines in the UAE. Public online pharmacy listings checked in September 2026 show EpiPen Jr 0.15 mg at about AED 314.50 and adult auto-injector listings around AED 435, but availability changes by pharmacy and insurer. A vial product can be far cheaper per unit, with one UAE medicine index listing adrenaline 1 mg/mL ampoules at AED 30.50 for a pack, but that is a professional-use format and cannot replace a prescribed auto-injector.

What operators should do this week

Dubai providers should complete a same-day search for the three lot numbers, document the result, and retain the evidence with the pharmacy quality file. DHA’s Sheryan circulars page includes recall notices for medical devices and pharmaceutical products, and it is the local feed private facilities should monitor. Abu Dhabi operators should check DOH recall and quarantine instructions; DOH has a published policy for quarantine and recall of medical products. Northern-emirate providers should check MOHAP and Emirates Drug Establishment updates.

The workflow should take less than 24 hours in a single-site clinic if the stock system records batch numbers. It will take longer where emergency medicines are stored outside the pharmacy system, including dental clinics, aesthetic centres and day-surgery units. Those sites should physically inspect labels, photograph affected lots, segregate any suspect vial, and record who authorised removal and replacement.

Patients in Dubai should keep prescribed epinephrine available until a doctor or pharmacist confirms a replacement plan. They should check the medicine name, strength and presentation, then call a licensed pharmacy or prescribing doctor if the product is a vial rather than an auto-injector. Insurance coverage varies by policy and network; Daman, Thiqa and Sukoon members should confirm benefit rules through their insurer or network pharmacy before paying cash.

Operators looking for verified dispensing or replacement channels should use the UAE Open Healthcare Directory to identify licensed pharmacy providers, then confirm availability, prescription requirements and batch details directly with the pharmacy before sending patients.